Alcohol-Induced Cirrhosis Model
Alcohol-Induced Cirrhosis Model
By leveraging validated ethanol-containing liquid diet regimens alone or in combination with secondary hit triggers, our platform models accurately reflect human disease pathology driven by chronic alcohol consumption.
Indications & Applications
- Preclinical Efficacy Screening for ALD & AH: In vivo therapeutic evaluation of small molecules, biologics, and novel drug candidates targeting Alcoholic Hepatitis (AH) and Alcoholic Liver Disease (ALD).
- Antifibrotic & Matrix Remodeling Therapies: Assessment of agents designed to inhibit hepatic stellate cell (HSC) transdifferentiation, suppress pericentral collagen deposition, or accelerate extracellular matrix degradation.
- Gut-Liver Axis & Endotoxemia Modulators: Validation of therapeutics targeting gut mucosal barrier integrity, intestinal microbiome restoration, microvascular permeability, and LPS/TLR4 signaling cascades.
- Anti-Steatotic & Antioxidant Interventions: Evaluation of metabolic regulators reducing hepatic lipid accumulation, suppressing CYP2E1-mediated oxidative stress, and attenuating lipid peroxidation.
- Regenerative Medicine & Biomarker Profiling: Pharmacodynamic (PD) profiling and translational safety assessment for stem cell, gene therapy, or tissue-repair modalities.
Modeling Methodologies
1. Lieber-DeCarli Chronic Ethanol Liquid Diet Model
Animals are pair-fed a nutritionally balanced liquid diet where ethanol replaces carbohydrate calories gradually over extended induction periods. Sustained ethanol metabolism via alcohol dehydrogenase (ADH) and CYP2E1 generates acetaldehyde and reactive oxygen species (ROS), driving consistent hepatic lipid accumulation, oxidative damage, and mild pericentral fibrosis.
2. Chronic-Plus-Binge Ethanol Model (NIAAA Model)
Combines 10 days to several weeks of Lieber-DeCarli liquid diet feeding followed by single or multiple acute ethanol gavage 'binges'. This acute-on-chronic paradigm induces a robust elevation in serum ALT/AST, marked neutrophil infiltration, and pronounced hepatocyte ballooning, closely mimicking acute alcoholic hepatitis in patients.
3. Two-Hit Accelerated Alcoholic Fibrosis Model (Ethanol + Low-Dose Co-Toxin / High-Fat)
Combines long-term ethanol feeding with secondary profibrotic triggers (such as low-dose CCl4, LPS administration, or a high-fat diet). The synergistic injury bypasses rodent resistance to ethanol-driven cirrhosis alone, accelerating the development of dense bridging fibrosis, pseudolobule formation, and marked HSC activation.
Clinical Relevance & Translation
- Gut-Liver Axis Dysfunction: Replicates ethanol-induced intestinal barrier breakdown, bacterial endotoxin (LPS) translocation, and subsequent TLR4 receptor activation on Kupffer cells.
- Metabolic & Oxidative Homology: Captures hallmark human pathological features including CYP2E1 up-regulation, mitochondrial dysfunction, lipid peroxidation, and steatotic ballooning.
- Inflammatory Infiltration: Captures hepatic neutrophil recruitment and pro-inflammatory signaling (TNF-α, IL-1β) typical of clinical alcoholic steatohepatitis (ASH).
Key Evaluation Endpoints
| Endpoint Domain | Specific Parameters & Assays | Pathological Significance |
|---|---|---|
| In Vivo & Metabolic Profiling | • Body Weight & Caloric Intake Dynamics • Liver-to-Body Weight Ratio • Blood Alcohol Concentration (BAC) Monitoring |
Validates systemic ethanol exposure levels and tracks gross metabolic impact. |
| Serum Biochemistry & Lipid Profile | • ALT, AST, ALP, γ-GT • Triglycerides (TG) & Free Fatty Acids (FFA) • Total Bilirubin & Albumin Levels |
Evaluates acute enzymatic liver injury, biliary dysfunction, dyslipidemia, and synthetic capacity. |
| Histopathology & Fibrosis Quantitation | • H&E & Oil Red O (Steatosis & Ballooning) • Sirius Red / Masson's Trichrome (Pericentral Collagen) • Morphometric Collagen Volume Fraction (CVF) |
Quantifies lipid droplet deposition, steatohepatitis scoring, and architectural ECM accumulation. |
| Molecular & Biomarker Analysis | • CYP2E1 & 4-HNE Expression • Serum Endotoxin (LPS) & MPO Activity • α-SMA, TGF-β1, TNF-α, IL-1β, IL-6 |
Assesses oxidative stress, gut permeability, neutrophil activity, HSC transdifferentiation, and cytokine cascades. |
Related Animal Models
Explore other gene-edited animal models that complement our porcine research platforms
